Research & Development: Page 73

  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Maintaining Clinical Operations in a Downward Economy: It's Just Good Business

    As pharmaceutical, biotechnology, and medical-device companies look to realize cost-efficiencies across the board to meet the demands of the current fiscal crisis, they should evaluate the consequences of budget cuts and staff attrition as they reorganize their clinical departments. While some am...

    By PharmaVoice Team • June 8, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    An Albatross and an Opportunity

    Economic necessity is driving our industry to look hard at how more efficient services and systems can be provided to support the clinical research process. There are those who would say this necessity was present before the recent economic meltdown. However, I have personally been involved in cl...

    By PharmaVoice Team • June 8, 2009
  • clinical trial diversity Explore the Trendline➔
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Trendline

    Clinical trial diversity

    As pharma wises up to the fact that the current playbook for improving clinical trial diversity has yet to make a meaningful impact, the quest is on to refine that approach.

    By PharmaVoice staff
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    You Can't Teach People to Care or Can You?

    Today, we easily recognize terrorism, pandemic flu, and hurricanes as potential disasters …the latter being an event that we in New Orleans know all too well. A hurricane named Katrina was our disaster…and a vivid example of how a lack of preparation and structural-weakness can eventually be cata...

    By PharmaVoice Team • June 8, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Supplier Showcase

    Aptuit, Inc. Two Greenwich Office Park Greenwich, CT 06831 Phone: 203-422-6600 Fax: 203-422-0266 www.aptuit.com World-Class Clinical Operations Aptuit’s Clinical Operations are focused on the critical steps that are essential in taking a novel compound and developing it into a safe and effe...

    By PharmaVoice Team • June 8, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Letter from the Editor

    Beyond the clouds At the moment, it can be difficult for drug developers to see beyond the economic cloud that currently shrouds the pharma industry. Based on her interviews with several pharmaceutical research and development executives, Carolyn Gretton, writer of this month’s Forum, reports th...

    By PharmaVoice Team • June 8, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    Madeira Therapeutics’ Peter Joiner Presents a Case for the Pediatric Market In the pediatric setting, I believe that Madeira as well as others committed to this arena have the responsibility of educating physicians as to how a drug should be used and what role it plays in a patient’s life. Peter ...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Kurt HARTMAN Dr. Craig HOPKINSON New Hires at Eisai Eisai Inc., a U.S. pharmaceuti cal subsidiary of Japan’s Eisai Co. Ltd., has appointed Kurt Hart man, J.D., senior director of value and access, with responsibility for integrating and aligning Eisai’s focus on reimbursement ...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    Symyx Grants ACCESS TO MOLECULE INFORMATION The Biotechnology Industry Organization (BIO) has launched the BIO Community (community.convention.bio.org) to provide free resources to biotechnology leaders and professionals in an effort to help them overcome the chal lenges currently facing the indu...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    What's New

    Vincent Aurentz, executive VP of portfolio devel opment, says this activity complements the compa ny’s tool kit of collaborative approaches to build a highquality portfolio with partners. “The creation of a venture capital fund under lines our commitment to be a best partner for biotech entrepren...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Pharma R&D Spending Remains Robust Despite Tough Economy Despite the current economic downturn, pharmaceutical research and development spending continues to play a vital role in the pharmaceutical industry. According to a recent report by CBR Pharma Insights, recent trends indicate a consoli...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaOutlet

    You are planning an upcoming investigators meeting. Going over your checklist, you check off sponsor, project manager, central laboratory, site coordinators, site monitors, principal investigators, and others involved in the research. Flights, hotel accommodations, and meals also have been arrang...

    By Lynn Meyer • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    ACRP 2009 Wrap Up

    ACRP 2009 Global Conference & Exhibition — Denver, April 24-28 A record crowd of about 3,000 attended the Association of Clinical Research Professionals (ACRP) 2009 Global Conference & Exhibition in Denver in April. Held in conjunction with the Academy of Pharmaceutical Physicians and Inv...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Annual DIA Preview Showcase

    SPECIAL FEATURE DIA 45TH ANNUAL MEETING We all share in the responsibility to work together to strengthen the science used in pharmaceutical product development, evaluation, and review,” says Program Chair Nancy Smith, Ph.D., former director of the Office of Training and Communications, CDER, at ...

    By PharmaVoice Team • May 25, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Meet the Chief Scientific Officers

    The CSO Role The chief scientist officer helps set a company’s strategy, interacts with investors and board of directors, and helps people understand the science behind new products. MCKERNAN. PFIZER. A CSO at Pfizer handles everything from the idea to proof of concept, establishing and building ...

    By Denise Myshko • May 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Upfront

    UPFRONT Milestones 20TH ANNIVERSARY John R. Vogel Associates Inc. celebrates 20 years of assisting pharmaceutical and biopharmaceutical companies and the pharmaceutical service providers to enhance results achieved through outsourcing and strategic alliances. Mr. Vogel, who founded the company in...

    By PharmaVoice Team • May 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Defining a Career Path in the New Pharmaceutical Era

    Avoiding the Bull’s-Eye When management needs to trim the workforce, there are ways to avoid being the target. The value of an employee increases if he or she has a can-do attitude, is a problem solver, and can react quickly to changes and challenges in the business environment. Binner. AstraZene...

    By Robin Robinson • April 27, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Creating Value through Personalized Medicine

    BY DENISE MYSHKO The use of pharmacogenomics to develop personalized medicine will lead to a culture change for the pharmaceutical industry. While initially disruptive, personalized medicine will lead to longer-term success for pharmaceutical companies. Dr. Gary Kurtzman Safeguard Scientifics The...

    By Denise Myshko • April 27, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Una Ryan, Ph.D.: Clear Intent

    BY KIM RIBBINK Dr. Una Ryan has made significant inroads in the biotechnology world. Not only has she helped to successfully navigate a company through major change, she has also played a key role in improving business conditions for other biotech companies. Now she is applying her forward-thinki...

    By Kim Ribbink • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Last Word

    The industry is outsourcing the activities that are going to be core to being prosperous in the future, while hanging on to activities that will provide less and less value. Disruption equals Opportunity Please explain the concept of disruptive innovation and the opportunities this poses for the ...

    By PharmaVoice Team • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Talent Pool

    Pharmaceutical POOL Andy AJELLO Novo Nordisk Appoints Diabetes Sales VP Novo Nordisk, a global healthcare company focusing on diabetes care, has promoted Andy Ajello to VP for national diabetes sales, managed care, and government accounts. Previously, Mr. Ajello was associate VP of diabetes sales...

    By PharmaVoice Team • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    E-Media

    New Electronic and Web-based Applications, Sites, and Technologies Featured Briefs: Model N Application Provides Strategic Insights to Life-Sciences Firms New Momentum Offers AntiCounterfeiting Software Novartis Launches Meningitis Website Website Highlights Pink Tank’s Expertise in Women’s Healt...

    By PharmaVoice Team • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    PharmaTrax

    Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Electronic Delivery of CME Gains Popularity Sidebar: Average % of CME Delivered Via Internet Smaller, Refocused Salesforces Could Create Greater Value for Patients Sidebar: Pharma Job Cuts Announced as of October 2008 Ef...

    By PharmaVoice Team • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    UpFront

    Milestones 10th anniversary marked with rebranding GxP Consulting (formerly GxPi Ltd.), a provider of compliance services to the pharma and biopharma industries, has launched its newly designed and improved Website and a new name as it celebrates 10 years in business. The new Website, accessible ...

    By PharmaVoice Team • April 23, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Differentiating KOLs and Advocates: The Importance of a Targeted Strategy

    The terms key opinion leader (KOL) and advocate are often used interchange ably; but, they define t w o very different target groups. A strategy to clearly identify and characterize KOLs, to then con vert them to and deploy them as advocates, and finally to build and maintain a lasting relationsh...

    By PharmaVoice Team • April 14, 2009
  • Image attribution tooltip
    PharmaVoice Team/PharmaVoice
    Image attribution tooltip

    Physician Learning: Improving the Process

    This program will profoundly improve my practice of medicine. It was exactly what I was looking for,” a primarycare physi cian recently stated as he was leaving a continuing medical education (CME) pro gram on hypertension. This is a high compliment indeed and a goal that all CME providers strive...

    By PharmaVoice Team • April 14, 2009